Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2

QR Code

Effects of thymoquinone and thymoquinone-loaded nanostructured lipid carrier on hepatocellular carcinoma cell models, Hep3B and HepG2

Hepatocellular carcinoma (HCC) is the fourth most common solid tumor. Dysregulated cell proliferation and tumorigenesis of HCC is commonly associated with chronic hepatitis B infection. Thymoquinone (TQ), a bioactive compound found in Nigella sativa has been shown to exhibit anti-tumor propert...

Full description

Bibliographic Details
Main Author:	Haron, Aminah Suhaila
Format:	Thesis
Language:	English
Published:	2017
Subjects:	Carcinoma, Hepatocellular Benzoquinones Liver Neoplasms
Online Access:	http://psasir.upm.edu.my/id/eprint/76561/ http://psasir.upm.edu.my/id/eprint/76561/1/FPSK%28M%29%202018%2039%20-%20IR.pdf

Similar Items

Cytotoxicity of Goniothalamin on the Human Hepatocellular Carcinoma HEPG2 Cell Line
by: Obaid Al-Qubaisi, Mothanna Sadiq
Published: (2009)

Thymoquinone-loaded nanostructured lipid carrier reduces proliferation of human liver cancer cells, HepG2
by: Mustafa Azmy, Nurfahima, et al.
Published: (2019)

Screening for hepatocellular carcinoma: patient selection and perspectives
by: Fateen, Waleed, et al.
Published: (2017)

Cytotoxic Effect of Girinimbine on HepG2 Cells
by: Mohan, Suvita Syam
Published: (2011)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2013)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Fateen, Waleed, et al.
Published: (2017)

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
by: Subramaniam, A., et al.
Published: (2012)

Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
by: Siveen, K., et al.
Published: (2014)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

Cytotoxicity effect of Thymoquinone-loaded nanostructured lipid carrier (TQ-NLC) on liver cancer cell integrated with hepatitis B genome, Hep3B
by: Haron, Aminah Suhaila, et al.
Published: (2018)

Antiproliferative effects of zerumbone-hydroxypropyl-ß-cyclodextrin inclusion complex on HepG2 liver cancer cells in vitro
by: Muhammad Nadzri, Nabilah
Published: (2013)

Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
by: Afriyie-Asante, Afrakoma
Published: (2019)

Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population-based cohort study
by: West, Joe, et al.
Published: (2017)

Effect of thymoquinone and thymoquinone-loaded nanostructured lipid carrier in in vitro wound healing model
by: Alexander, Henna Roshini
Published: (2019)

Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression by thymoquinone-rich fraction and thymoquinone in HepG2 cells
by: Al-Naqeep, Ghanya, et al.
Published: (2009)

Iron and Hepatic Carcinogenesis
by: Tirnitz-Parker, Janina, et al.
Published: (2013)

New method for improving solubilization and uptake of lutein and carotenoids in human hepatocellular liver carcinoma (HepG2) cell culture
by: Lestari, Widya, et al.
Published: (2014)

New Method for Improving solubilization and uptake of lutein and carotenoids in human hepatocellular liver carcinoma (HepG2) cell culture
by: Jaswir, Irwandi, et al.
Published: (2009)

Improvement of solubilization and uptake of dietary antioxidants in human hepatocellular liver carcinoma (HepG2) cell line (PDNP4)
by: Jaswir, Irwandi, et al.
Published: (2009)

Morphological changes in liver cells of hypercholesterolaemic-induced rats and hepG2 cell lines associated with edible bird’s nest supplementation
by: Mohd Noor, Mohd Akmal
Published: (2020)

Thymoquinone loaded nanostructured lipid carriers (TQ-NLC) and uses thereof
by: Saiful Yazan, Latifah, et al.
Published: (2012)

New method for improving solubilization and uptake of lutein and beta-carotene in human hepatocellular liver carcinoma (HepG2) cell culture
by: Jaswir, Irwandi, et al.
Published: (2010)

Migration and proliferation effects of Thymoquinone-loaded nanostructured lipid carrier (TQ-NLC) and Thymoquinone (TQ) on in vitro wound healing models
by: Alexander, Henna Roshini, et al.
Published: (2019)

Toxicity and anti-breast cancer properties of thymoquinone-loaded nanostructured lipid carrier in mice
by: Ong, Yong Sze
Published: (2019)

Antioxidant behaviour of carotenoids highly accumulated in HepG2 cells
by: Jaswir, Irwandi, et al.
Published: (2012)

Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.
by: Al-Qubaisi, Mothanna, et al.
Published: (2011)

Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics
by: Elmorsy, E., et al.
Published: (2016)

Gamma-tocotrienol alters protein expression of HepG2 cell line
by: Farahani ARS,, et al.
Published: (2008)

Zerumbone Exerts Antiproliferative Activity via Apoptosis on HepG2 Cells
by: Syed Alwi, Sharifah Sakinah, et al.
Published: (2007)

Suppression effect of eurycomanone on the growth of HepG2 tumour transplanted in mice
by: Zakaria, Yusmazura
Published: (2011)

Cytotoxicity of thymoquinone and thymoquinone-loaded nanostrustured lipid carrier on cervical cancer cells (SiHa and HeLa)
by: Ng, Wei Keat
Published: (2015)

Cytotoxicity of Clinacanthus Nutans Extracts on Human Hepatoma (HepG2) Cell Line
by: Hazrulrizawati, Hamid, et al.
Published: (2016)

Acute and sub-acute toxicity profile of thymoquinone-loaded nanostructured lipid carrier (TQNLC) in BALB/c mice
by: Yong, Sze Ong, et al.
Published: (2016)

Role of oxidative stress in antituberculous drugs (individuals and combined) cytotoxicity in HepG2 cells
by: Elmorsy, Ekramy, et al.
Published: (2016)

Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53
by: Zakaria, Yusmazura, et al.
Published: (2009)

Vanillin rich fraction regulates LDLR and HMGCR gene expression in HepG2 cells.
by: Ismail, Maznah, et al.
Published: (2010)

Cytotoxic effects of conjugated linoleic acids on human hepatoma cancer cells (HepG2)
by: Melaku, Achenef, et al.
Published: (2012)

Production and characterization of phycobiliproteins from cyanobacteria and their effects on HepG2 cancer cell lines
by: Begium, Hasina
Published: (2014)

Construction of blackberry polysaccharide nano-selenium particles: Structure features and regulation effects of glucose/lipid metabolism in HepG2 cells
by: Zu-Man, Dou, et al.
Published: (2024)

Acute toxicity study of intravenous administration of thymoquinone-loaded nanostructured lipid carrier (TQ-NLC) in Sprague dawley rats
by: Saiful Yazan, Latifah, et al.
Published: (2019)